Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Are The Market Size Estimates For The DNA Microarray Market?

The market size of the dna microarray has significantly increased in the past few years. It is projected to escalate from $3.38 billion in 2024 to $3.78 billion in 2025, with a compound annual growth rate (CAGR) of 11.9%. Factors contributing to the growth during the historic period include advancements in pharmacogenomics, improvements in healthcare infrastructure, collaborations and partnerships, reduction in costs, and a heightened level of public awareness and education.

The dna microarray market is projected to experience significant expansion in the coming years, growing to a size of $5.82 billion by 2029 with a compound annual growth rate (CAGR) of 11.4%. This projected growth during the forecast period is due to factors such as the rise in personalized medicine, the advent of comparative genomic hybridization (CGH), developments in agricultural genomics, approvals and standardization by regulatory authorities, and the increasing incidence of chronic diseases. Key trends observed during the forecast period are progress in genomic research, increased financial support for genomic investigations, technological breakthroughs, synergies with other technologies, and technological progress.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16039&type=smp

Which Industry Forces Are Driving The DNA Microarray Market Forward?

The increasing uptake of personalized medicine is predicted to drive the DNA microarray market’s expansion. By considering each patient’s unique characteristics – encompassing genetic, environmental, and lifestyle factors – personalized medicine customizes medical treatment to boost therapeutic efficacy and outcomes. The swift evolution of ‘omics’ technology, the integration of data, genetic knowledge, and a perception of the import of specific patient medications and preventive actions, has given rise to this field. DNA microarrays facilitate personalized medicine by scrutinizing gene expression patterns, thus promoting customized treatment strategies based on a person’s genetic profile. For example, in February 2024, it was reported by the Personalized Medicine Coalition, a non-profit organization based in the US, that the FDA had given their approval to 16 new personalized therapies designed for patients with rare diseases in 2023, a significant boost from the 6 approved in 2022. As such, the brisk uptake of personalized medicine is fueling the growth of the DNA microarray market.

How Is The DNA Microarray Market Organized By Different Segments?

The dna microarraymarket covered in this report is segmented –

1) By Type: Complementary DNA Microarrays; Oligonucleotide DNA Microarrays; Other Types

2) By Application: Gene Expression Analysis; Genotyping; Other Applications

3) By End-user: Pharmaceutical And Biotechnology Companies; Diagnostic Centers; Hospitals And Clinics; Academic And Research Institute; Other End-Users

Subsegments:

1) By Complementary DNA Microarrays: Gene Expression Profiling; Comparative Genomic Hybridization (CGH); Quantitative Analysis

2) By Oligonucleotide DNA Microarrays: Gene Expression Microarrays; Single Nucleotide Polymorphism (SNP) Arrays; DNA Methylation Arrays; Pathogen Detection Arrays

3) By Other Types: Protein-DNA Microarrays; Tissue Microarrays; Affinity Microarrays; Spotted DNA Microarrays

What Key Trends Are Driving Growth In The DNA Microarray Market?

Companies at the forefront of the DNA microarray market are striving for the development of superior technology that boasts a turnaround time of just two days, in an effort to edge out competition. The swiftness and efficiency of a two-day turnaround time in microarray analysis allows for more rapid decision-making in both research and clinical settings. As an illustration, Thermo Fisher Scientific Inc., a leading biotechnology corporation from the United States, launched the Applied Biosystems CytoScan HD Accel array in August 2023. This new chromosomal microarray aims to boost productivity, operational efficiency and profits in cytogenetic research laboratories, while offering a top-notch two-day turnaround time. The CytoScan HD Accel array conducts comprehensive genome analysis with an enhanced reach into over 5,000 crucial genomic regions, providing essential details about chromosomal variations applicable in prenatal, postnatal, and cancer research.

Who Are The Primary Market Leaders In The DNA Microarray Market?

Major companies operating in the DNA microarray market are Roche Holding AG, Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., bioMérieux SA, Schott AG, Bio-Rad Laboratories Inc., QIAGEN N.V., Bioneer Corporation, CapitalBio Technology Co. Ltd., Eurofins Genomics LLC, Savyon Diagnostics Ltd., Oxford Gene Technology, Sengenics Corporation LLC, Affymetrix, BioCat GmbH, Scienion AG, LC Sciences, Arrayit Corporation, Akonni Biosystems Inc., Arraystar Inc., Febit Holding GmbH

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/dna-microarray-global-market-report

How Do Regional Dynamics Influence The DNA Microarray Market Performance?

North America was the largest region in the DNA microarray market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the DNA microarray market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=16039&type=smp

Browse Through More Reports Similar to the Global DNA Microarray Market 2025, By The Business Research Company

Dna Based Skin Care Products Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dna-based-skin-care-products-global-market-report

Dna And Gene Chip Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dna-and-gene-chip-global-market-report

Recombinant Dna Technology Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/recombinant-dna-technology-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model